WHO ICTRP trial
Medical expulsive therapy for ureter stone using Naftopidil
KCT0001289 · Clinical Research Information Service (CRIS) · Not Recruiting
Key facts
| Trial ID | KCT0001289 |
|---|---|
| Public title | Medical expulsive therapy for ureter stone using Naftopidil |
| Scientific title | Medical expulsive therapy for ureter stone using Naftopidil: Multicenter, randomized, double-blind, placebo controlled study |
| Primary sponsor | Seoul National University Hospital |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Not Recruiting |
| Study type | Interventional Study |
| Phase | Phase3 |
| Countries | Korea, Republic of |
| Conditions | Diseases of the genitourinary system |
| Interventions | Drug : Control group would receive standard treatment of analgesics and experimenta l group would receive analgesics with naftopidil 75mg po qd. Patients take the naftopidil for 14 days, and can do the analegecis according to the pain… |
| Registration date | Dec 1, 2014 |
| Target size | 150 |
| Secondary IDs | NCT01952314 |
| Registry page | cris.nih.go.kr |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: